From Corporate Philanthropy to Creating Shared Value: Big Pharma’s New Business Models in Developing Markets
By: N. Craig Smith
Authors
N. Craig Smith
DOI: https://doi.org/10.1515/gfkmir-2016-0005 | Journal eISSN: 2628-166X
Language: English
Page range: 30 - 35
Published on: Apr 29, 2016
Published by: Nuremberg Institute for Market Decisions
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2016 N. Craig Smith, published by Nuremberg Institute for Market Decisions
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.